Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich, Nussbaumstrasse 7, 80336 Munich, Germany.
Eur Psychiatry. 2012 Oct;27(7):547-52. doi: 10.1016/j.eurpsy.2011.01.004. Epub 2011 Mar 9.
Self-ratings of psychotic experiences might be biased by depressive symptoms.
Data from a large naturalistic multicentre trial on depressed inpatients (n=488) who were assessed on a biweekly basis until discharge were analyzed. Self-rated psychotic symptoms as assessed with the 90-Item Symptom Checklist (SCL-90) were correlated with the SCL-90 total score, the SCL-90 depression score, the Beck Depression Inventory (BDI), the Hamilton Depression Rating Scale 21 item (HAMD-21) total score, the Montgomery Åsberg Depression Rating Scale (MADRS) total score and the clinician-rated paranoid-hallucinatory score of the Association for Methodology and Documentation in Psychiatry (AMDP) scale.
At discharge the SCL-90 psychosis score correlated highest with the SCL-90 depression score (0.78, P<0.001) and with the BDI total score (0.64, P<0.001). Moderate correlations were found for the MADRS (0.34, P<0.001), HAMD (0.37, P<0.001) and AMDP depression score (0.33, P<0.001). Only a weak correlation was found between the SCL-90 psychosis score and the AMDP paranoid-hallucinatory syndrome score (0.15, P<0.001). Linear regression showed that change in self-rated psychotic symptoms over the treatment course was best explained by a change in the SCL-90 depression score (P<0.001). The change in clinician-rated AMDP paranoid-hallucinatory score had lesser influence (P=0.02).
In depressed patients self-rated psychotic symptoms correlate poorly with clinician-rated psychotic symptoms. Caution is warranted when interpreting results from epidemiological surveys using self-rated psychotic symptom questionnaires as indicators of psychotic symptoms. Depressive symptoms which are highly prevalent in the general population might influence such self-ratings.
自评的精神病体验可能会受到抑郁症状的影响。
对接受双周评估直至出院的 488 例住院抑郁症患者的大型自然主义多中心试验数据进行了分析。使用 90 项症状清单(SCL-90)自评精神病症状,并与 SCL-90 总分、SCL-90 抑郁得分、贝克抑郁量表(BDI)、汉密尔顿抑郁量表 21 项(HAMD-21)总分、蒙哥马利抑郁评定量表(MADRS)总分以及精神病学方法和文献协会(AMDP)评定的临床医生评定的偏执-幻觉评分相关。
在出院时,SCL-90 精神病评分与 SCL-90 抑郁评分(0.78,P<0.001)和 BDI 总分(0.64,P<0.001)相关性最高。与 MADRS(0.34,P<0.001)、HAMD(0.37,P<0.001)和 AMDP 抑郁评分(0.33,P<0.001)呈中度相关。SCL-90 精神病评分与 AMDP 偏执-幻觉综合征评分仅呈弱相关(0.15,P<0.001)。线性回归显示,治疗过程中自评精神病症状的变化主要由 SCL-90 抑郁评分的变化来解释(P<0.001)。临床医生评定的 AMDP 偏执-幻觉评分的变化影响较小(P=0.02)。
在抑郁症患者中,自评精神病症状与临床医生评定的精神病症状相关性较差。在使用自评精神病症状问卷作为精神病症状指标的流行病学调查中,解释结果时需要谨慎。在普通人群中普遍存在的高度流行的抑郁症状可能会影响这种自评。